bioMerieux

Activities: Regulatory Analysis

Trending Articles

  1. NHS, MHRA and Medicines UK launch Project Revive to tackle medicine shortages NHS England, the MHRA and Medicines UK have launched Project Revive, a collaborative pilot designed to address critical medicines shortages by fast-tracking dormant...
  2. Isopod Rapid Cleanrooms: the ideal elite controlled environment pod solution for Life Sciences and Engineering start-ups The Guardtech Group’s quick-assembly cleanroom pods combine superior performance, build quality and cost-effectiveness to give new applications the perfect platform to get...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Delivering precision: why advanced therapies are redefining pharmaceutical logistics As advanced therapies narrow tolerances and personalise care, pharmaceutical logistics is being redefined as a precision-driven extension of treatment delivery, writes Michael...
  4. Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic...
  5. AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery...

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

Related Content

Regulatory

bioMérieux and JMI Laboratories partner to fight antimicrobial resistance

JMI Laboratories is a recent member of the Element Group, a leading global Testing, Inspection and Certification (TIC) company, through acquisition in November 2021
Drug Delivery

InDevR raises $9m in series B financing

ioMérieux will also become the exclusive distributor of the VaxArray portfolio in Europe
Regulatory

bioMérieux receives FDA clearance for mass spectrometry ID system

With 1.3 million deaths worldwide annually, antimicrobial resistance (AMR) is a global health priority
Manufacturing

Recombinant Factor C assay to aid demand for LAL endotoxin testing

Kevin Williams from bioMerieux discusses the recombinant Factor C assay that has been developed to help alleviate the pressures of a growing demand for the Limulus amoebocyte lysate assay
Analysis

bioMérieux launches automated diagnostic solution for microbial detection

EviSight Compact provides reliable results for increased product safety and reduces costs for pharmaceutical companies
Finance

BioMérieux acquires Hyglos for a total consideration of €24m

Expands its offering for the detection of endotoxins in pharmaceutical products
Analysis

Revolutionised and Robust: Environmental Identification Webinar - mid-October

Environmental identification, including moulds, by MALDI-TOF Mass Spectrometry
Subscribe now